Sec Form 3 Filing - Neville Everett @ Cigna Group - 2025-03-31

FORM 3 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Neville Everett 2. Issuer Name and Ticker or Trading Symbol Cigna Group [ CI] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) See Remarks (Last) (First) (Middle) 900 COTTAGE GROVE RD 3. Date of Earliest Transaction (MM/DD/YY) 03/31/2025 (Street) BLOOMFIELD, CT06002 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock, $.01 Par Value 3,509 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Employee Stock Option (Right to Buy) $ 227.02 03/01/2023( 1 ) 02/23/2032 Common Stock, $.01 Par Value 3,622 D Employee Stock Option (Right to Buy) $ 294.61 03/01/2024( 2 ) 02/22/2033 Common Stock, $.01 Par Value 4,391 D Employee Stock Option (Right to Buy) $ 305.855 03/01/2026( 3 ) 02/28/2035 Common Stock, $.01 Par Value 6,386 D Employee Stock Option (Right to Buy) $ 336.475 03/01/2025( 4 ) 02/28/2034 Common Stock, $.01 Par Value 6,091 D Phantom Stock Units $ 0 ( 6 ) ( 5 ) ( 5 ) Common Stock, $.01 Par Value 11,728.9306 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Neville Everett 900 COTTAGE GROVE RD BLOOMFIELD, CT06002 See Remarks Signatures Tyler Gratton, attorney-in-fact 04/09/2025 Signature of Reporting Person Date

Explanation of Responses:

( 1 )This option is fully vested. ( 2 )This option was granted on February 22, 2023 and vests in three equal annual installments. The first two installments became exercisable on March 1, 2024 and March 1, 2025, and the last installment becomes exercisable on March 1, 2026. ( 3 )This option vests in three equal annual installments beginning March 1, 2026. ( 4 )This option was granted on February 28, 2024, and vests in three equal annual installments. The first installment became exercisable on March 1, 2025, and the next two installments become exercisable on March 1, 2026 and March 1, 2027. ( 5 )Phantom stock units are payable in cash in accordance with the terms of the Express Scripts, Inc. Executive Deferred Compensation Plan. The reporting person may transfer his interests in The Cigna Group stock fund into an alternative investment fund. ( 6 )Represents phantom stock units under The Cigna Group stock fund of the Express Scripts, Inc. Executive Deferred Compensation Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group common stock and is to be settled in cash.

Remarks: EVP, Strategy and Business DevelopmentExhibit List: EX-24 Power of Attorney poaneville.txt

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.